Objectives-To evaluate the utility of ultrasound-based shear wave elastography (SWE) as a noninvasive method to accurately detect and potentially stage the severity of renal allograft fibrosis and assess its user reproducibility.
C hronic rejection is the most common cause of renal allograft loss. 1 Recent literature has replaced the term "chronic rejection" with the more histologically descriptive term "interstitial fibrosis and tubular atrophy." This condition often presents as progressive and insidious allograph dysfunction characterized by a slow loss of renal function. It may manifest as new or worsening hypertension, an increasing serum creatinine level, a downtrending estimated glomerular filtration rate, or proteinuria. behind actual graft damage, at which point the injury may be irreversible.
Currently, biopsy remains the reference standard for assessing renal allograft dysfunction, including estimating fibrosis. However, biopsy remains an imperfect standard, with limitations and inherent risks, including sampling errors, allograft trauma sustained with multiple needle pass attempts, and large interobserver variation in interpreting biopsy samples among pathologists. 4 Furthermore, biopsy is neither reasonable nor feasible for every fluctuation in the renal allograph status. Complications of biopsy include bleeding (ranging from gross hematuria to perirenal hematomas), arteriovenous fistula formation, infection, and pseudoaneurysms. 4 Although rare, if bleeding complications become severe, hospital admission and further intervention may be necessary, thus increasing health care costs. Transplant loss is a rare but devastating complication.
Quantitative methods of elastographic measurement are well established in the liver fibrosis patient population, for both screening purposes and monitoring disease progression. Monodimensional elastographic modalities, such as transient elastography (FibroScan; Echosens, Paris, France), have been well documented in the literature [5] [6] [7] [8] [9] and have afforded patients with chronic hepatitis a noninvasive option for surveillance. Acoustic radiation force impulse (ARFI, prototype: Acuson S2000; Siemens Medical Solutions, Mountain View, CA), has also become a popular option used to evaluate both liver and renal disease. More advanced 2-dimensional elastographic modalities, such as advanced ARFI systems, SuperSonic shear imaging (SuperSonic Imagine, Aix-enProvence, France), and shear wave elastography (SWE), have also come into commercial use. [10] [11] [12] All of these modalities have emerged in recent literature to evaluate renal fibrosis in patients with chronic renal disease or in attempt to predict outcomes in transplanted renal allografts. [13] [14] [15] Unfortunately, the use of elastography in assessing renal allograft fibrosis remains controversial, as prior published results have been conflicting [16] [17] [18] [19] [20] [21] [22] ; furthermore, the way in which these modalities were used across these various studies was not uniform, so an exact comparison of results cannot be made.
For these reasons, we conducted our own prospective study both to determine whether SWE of the transplanted kidney could provide a noninvasive alternative to detect and possibly stage renal allograft fibrosis as well as to determine user reproducibility. We also discuss our technique, in detail, as we performed prebiopsy SWE measurements of both the cortex and the medulla (separately) with their histologic biopsy results, diagnosed according to the 2007 working Banff classification system for renal allografts.
Materials and Methods

Design Overview and Study Population
Institutional Ethics Committee approved this singlecenter prospective Health Insurance Portability and Accountability Act-compliant study. The study had full human subject approval through the Institutional Review Board of the University of California Davis Medical Center. We analyzed 70 preselected prospectively enrolled renal transplant patients from August 2015 through February 2016 at our institution. These patients were either scheduled for standard-of-care renal transplant biopsy (at their 3-month post-transplant date, regardless of whether renal allograft dysfunction was suspected) or had serologic evidence of evolving renal allograft dysfunction. Patients underwent prebiopsy B-mode ultrasound (US) imaging, followed by SWE, followed directly by biopsy.
Patients were included if they were older 18 years, were capable of providing autonomous informed consent, and underwent their renal transplantation at our institution. Four patients in our study had pediatric en bloc kidney transplants; the rest had standard-donor criteria adult renal allografts. Two patients had undergone a prior renal transplant and were on their second kidney transplant at the time of biopsy. Two patients were on their third renal transplant. These were included in our study. Exclusion criteria included pediatric patients (age < 18 years), time less than 3 months out from transplant surgery, presence of perinephric fluid collections, hydronephrosis, renal cysts, or other parenchymal disease, and documented renal artery stenosis. Patients were also excluded if they had undergone additional organ transplants (most often liver), in an effort to reduce confounders.
Shear Wave Elastographic Examinations
Patients underwent Shear SWE examinations using a LOGIQ E9 system and its C1-6-D broadband curvilinear transducer (GE Healthcare, Wauwatosa, WI). All gain settings in the SWE mode were standardized to a set gain of 80 db. A single sonographer who received specific training performed all SWE examinations (J.M.A., with 9 years of US experience) and also performed the US examinations during allograft biopsy. Bmode US examinations were performed on all patients with the same broadband C1-6-D curvilinear transducer as used for SWE examinations. Conventional pre-SWE US imaging included standard B-mode images displaying renal allograph morphologic features (length measured in the anteroposterior direction) and assessment of perirenal abnormalities. Renal cortical thickness and cortical-medullary boundaries were established with both color Doppler and B-flow imaging to visualize the interlobar and arcuate arteries ( Figure 1 ).
The LOGIQ E9 system uses a combination of transient ARFI (high-intensity US) induced in target tissues by a succession of focused US beams at a very high frame rate, allowing the system to capture the propagation of shear waves in real time. 23 This process allows the US system to acquire multiple images continuously in the cine clip mode. The data acquisition time is typically on the order of 100 milliseconds. 24 Shear wave elastographic results were qualitatively displayed in a color elastographic box, or elasticity image, which was overlaid on top of the larger field-of-view B-mode image ( Figure  2 ), which was manually positioned and adjusted per patient for optimization. Shear wave elastographic measurements were precisely obtained within a given elastographic box using regions of interests (ROIs), which were individually sized and placed, tailored to each image. Region of interest placement was performed after completion of an SWE examination, during the postprocessing period on the same equipment.
All patients were instructed to urinate before the examination in an effort to diminish artificially increased intrarenal pressures. All patients fasted for at least 2 hours before the examination. Our patients were then placed in a completely flat and supine position for all parts of the examination. They were instructed to remain completely still throughout all shear wave acquisitions and to breathe normally, unless a substantial motion artifact was observed ( Figure 3 ). In that case, the patient was guided through a series of neutral 5-second breath holds during the elastographic acquisition. Per patient, a maximum of five 5-second cine clips were acquired in the region most likely to be biopsied. Skin compression was limited to the sonographer's most gentle pressure required to acquire a suitable color elastographic box with good color fill and without evidence of a compression artifact (Figure 4 ). This artifact is better detailed in "Discussion." Rectangular elastographic boxes were individually adjusted by the sonographer to include and maximize both cortical and medullary compartments.
Postprocessing
Postprocessing of the images was performed after each examination was completed and was accomplished by 2 users (H.M.E. and E.C.C., both resident physicians), who were blinded to each other's results. H.M.E. was present for and observed the entire performance of all SWE examinations for each patient. Regions of interest were individually selected to measure quantitative SWE values in desired anatomic locations. The ROI area was standardized to 0.1 cm 2 . Cortical versus medullary boundaries were confirmed before ROI placement via a combination of analyses of SWE images and pre-SWE B-flow and color Doppler images, which allowed visualization of the arcuate arteries and thus the boundary of the cortex from the medulla. Per patient, 10 cortical ROI measurements and 10 medullary ROI measurements were selected for, analyzed, and averaged separately ( Figure 5 ). The mean, median, and standard deviation for all SWE values were automatically calculated by the US system, and results were reported in kilopascals using the Young modulus. All measurements were recorded and used for subsequent statistical analyses, including both the mean and median SWE values per each compartment. 
Biopsy Sampling and Histologic Correlation
All patients underwent allograft biopsy immediately after the SWE examination, which was performed on an outpatient basis. Biopsy samples were obtained with an 18-gauge Tru Core II disposable automatic biopsy needle (Argon Medical Devices, Inc, Plano, TX). They were performed under direct US supervision by 1 of 3 transplant nephrologists, each with greater than 20 years of experience. Biopsy samples were taken in the region of the allograft located closest to the skin surface, with the exact location individually tailored on a case-by-case basis. Extreme care was taken to correlate the biopsy sample site with the SWE examination site, and the same sonographer who performed the SWE examination also provided US imaging during biopsy guidance. Cytopathologists were on site to immediately evaluate each biopsy specimen for sample adequacy before being sent for full histologic grading. Sample adequacy was defined by the 1997 Banff criteria as a biopsy sample consisting of at least 10 or more glomeruli and at least 2 arteries, the threshold for minimal sample being 7 glomeruli and 1 artery from at least 2 separate cores containing 2 separate cortical areas. 2, 25 All biopsy specimens were placed in formalin, fixed and embedded in paraffin, and stained with hematoxylin-eosin, Masson's trichrome, and periodic acid-Schiff stains. The renal allograft evaluation and histologic staging were based on the Banff 2007 classification of renal allograft pathology, 26 Banff 1997 classification, 25 and "Banff 2013 meeting report." 27 All pathologic specimens were sent to the same institution for a specialized evaluation and final diagnosis (Department of Pathology, University of California, Los Angeles, CA). The severity of interstitial fibrosis and tubular atrophy was divided into the standard 4 categories: F0 (none), F1 (mild fibrosis, 25% interstitial fibrosis and tubular atrophy of the cortical area), F2 (moderate fibrosis, 26%-50% interstitial fibrosis and tubular atrophy of the cortical area), and F3 (severe fibrosis, > 50% interstitial fibrosis and tubular atrophy of the cortical area).
Statistical Analyses
All analyses were performed with SAS version 9.4 software (SAS Institute Inc, Cary, NC). All SWE measurements were expressed in kilopascals. The association between SWE values and the presence of fibrosis was examined by 2 approaches. The first approach examined whether SWE could determine if, overall, the patient had fibrosis using a logistic regression model, with biopsy results categorized into 2 groups: either the presence or absence of chronic fibrosis (yes/no). Next, the biopsy and affiliated SWE results were stratified into 4 groups by the severity of fibrosis: normal/no fibrosis, acute tubular injury (no chronic changes), mild fibrosis (25% fibrosis of the cortical area), and moderate fibrosis (26%-50% fibrosis of the cortical area), with differences in SWE values tested by analysis of variance. Because our US system calculated both the mean and median values for all 10 measurements, we wanted to determine which was more indicative of fibrosis. Univariate logistic regression models were fit to test for associations between the various SWE measurements and the occurrence of fibrosis.
Shear wave elastographic values and fibrosis scores were categorized by using the total range of acquired SWE values into 3 categories: high (1 SD above the mean), midrange (61 SD from the mean), and low (<1 SD below the mean) for both the cortex and medulla. The Fisher exact test was used to test for associations between the categorical SWE values and fibrosis.
For determining reproducibility, intraobserver and interobserver correlations were also estimated. Pearson correlations were estimated to examine the strength of the relationship between the mean and median shear wave moduli for both the medulla and the cortex. 28 Analysis of variance was used to test for differences in SWE between the different body mass index (BMI) categories of underweight, normal, overweight, and obese. The BMIs were divided into groups and categorized as 0 5 BMI less than 18 kg/m 2 (underweight), 1 5 18.5 to 24.9 kg/m 2 (normal), 2 5 25.0 to 29.9 kg/ m 2 (overweight), and 3 5 30 kg/m 2 or higher (obese). Univariate logistic regression models were fit to test for associations between the BMI, the various SWE measurements, and the occurrence of fibrosis. We also fit a multivariable logistic regression model in which the average median cortex and medulla measurements and BMI were fit simultaneously. The Fisher exact test was used to test for associations between high (>1 SD from the mean), midrange (61 SD from the mean), and low (<1 SD from the mean) shear waves for both the cortex and medulla.
Results
Renal biopsy was successfully completed in all cases. Aside from local discomfort, no major complications were observed. All patients were discharged home on the same day after the standard postprocedural observation period. Demographics and clinical characteristics of our study population are reported in Table 1 . All patients received at least 2 immunosuppressive agents. Prednisone was additionally given to 24 patients who had a particularly high risk of rejection, as indicated by high panel reactive antibody scores, which usually indicated prior antibody sensitization and represented a higher risk of rejection.
Seventy-three patients were initially enrolled in our study. Three were excluded for suboptimal images. The remaining 70 enrolled patients had an average age of 53 years (range, 25-74 years). Fifty-five patients underwent biopsy according to our routine 3-mo follow up protocol, whereas 15 patients underwent biopsy because of a suspicion of graft dysfunction. Forty patients had normal pathologic results, indicating no chronic or interstitial fibrosis and tubular atrophy changes. Seven patients had acute tubular injury, a clinical situation in which chronic changes cannot be accurately assessed. Twenty-three patients had fibrosis: 15 mild (25% interstitial fibrosis and tubular atrophy of the cortical area) and 8 moderate (26%-50% interstitial fibrosis and tubular atrophy of the cortical area). One patient was borderline for moderate to severe fibrosis and was grouped into the moderate category for statistical power. No patients had severe fibrosis in our study, defined as greater than 50% fibrosis of the cortical sample.
The average of all SWE measurements between the observers within the renal cortex was 12.4 kPa, with an SD of 3.66 kPa. The average of all SWE measurements within the renal medulla was 11.1 kPa, with an SD of 2.93. Neither the cumulative cortex nor the cumulative medulla results showed statistically significant findings associated with fibrosis across the 3 SWE categories. For the cortex, P > .99, indicating that no evidence was found for a relationship between cortical SWE values and fibrosis. However, the medulla revealed a trend toward significance (P 5 .114) and showed increasing proportions of fibrosis (percentage of patients with fibrosis) across increasing SWE categories (18.18% for low SWE values, 31.1% for midrange SWE values, and 57.1% predictive of fibrosis for high SWE values; Figure 6 ).
Analysis of the median versus the mean SWE results showed no significant associations between mean cortical, median cortical, or mean medullary SWE values (P 5 .32, .37, and .06, respectively) and fibrosis ( Figure  7) . However, the association between fibrosis and median medulla SWE values reached statistical significance (P 5 .04; Table 2 and Figure 8) . Furthermore, as the odds ratio indicates (Table 2) , for every kilopascal increase in the median medulla SWE measurement, the likelihood of fibrosis increased by about 20%. Low medullary SWE values also showed a trend toward significance (P 5 .0709), suggesting that lower medullary values may indicate a lower likelihood of fibrosis. When our data were analyzed via the Fisher exact test to determine whether discrete categories of fibrosis could be For the cortex, the intraobserver correlation was high for both the mean and median SWE measurements (r 5 0.98 and 0.97, respectively; P < .0001). The interobserver correlation was moderately high for mean SWE measurements (r 5 0.83; P < .0001), while the median cortical SWE measurements were less strongly correlated but still significant (r 5 0.76; P < .0001). For the medulla, both the mean and median results were highly correlated for intraobserver variation (r 5 0.95 and 0.98; P < .0001). However, low interobserver agreement was seen when comparing observer 1 and observer 2 measurements for both the mean and median medullary SWE results (r 5 0.50 and 0.48; P < .0001).
Finally, as we progressed through our study, we anecdotally noticed that patients with a higher BMI tended to have lower SWE values ( Figure 9 ). This finding was qualitatively appreciated when viewing the color Figure 7 . Association between high, medium, and low SWE values in the cortex. A low SWE value was defined as 1 SD (3.66 KPa) or greater below the mean of 12.4 KPa, medium as between 61 SD, and high as greater than 1 SD above the mean. P 5.89. . Association between high, medium, and low SWE values in the medulla. A low SWE value was defined as 1 SD (2.93 KPa) or greater below the mean of 11.1 KPa, medium as between 61 SD, and high as greater than 1 SD above the mean. P 5.095. For determining the presence of fibrosis (yes or no), the median and mean SWE values for the cortex and the medulla were analyzed separately. Only the median medulla SWE values reached statistical significance with the presence of allograft fibrosis. We found no statistical significance for the mean or median cortical SWE values or the mean medullary SWE values (although mean medullary results were close).
elastographic boxes for SWE measurements. We noticed that, particularly in our obese patients (defined as BMI > 30 kg/m 2 ), the elastographic boxes did not fill as completely as with our normal and overweight patients, and the overall color scheme within the elastographic box trended toward the lower end of the color spectrum (which reflects lower SWE values). However, this observation was not confirmed in our data analysis, as the analysis of variance result was not significant (P 5 .16), and neither the univariate nor multivariate logistic regression revealed significant associations between the BMI and fibrosis (P 5 .76 and .67, respectively).
Discussion
To date, there is no general consensus on the use of SWE for detecting fibrosis in renal allografts. Some studies have found a positive correlation with renal allograft elasticity and the degree of fibrosis, whereas others have not. [16] [17] [18] [19] [20] [21] [22] 29 Further complicating interpretations of these studies' results were different modalities used to evaluate fibrosis and even the species in which these modalities were studied. For example, Arndt et al 16 demonstrated that allograft stiffness values were significantly correlated with the extent of fibrosis in renal allografts using the FibroScan modality, which uses transient elastography. This result is interesting, as transient elastography is not an image-guided modality. Thus, examiners would not know whether they are examining the renal cortex, medulla, or perinephric fat. Furthermore, there is a specific focal zone with FibroScan that has been shown to be less effective in accurately evaluating fibrosis in the liver in more obese patients. Stock et al 30 also described a positive correlation between renal allograft fibrosis and SWE values but by using ARFI, and results by Grenier et al 17 also suggested a positive correlation between cortical renal stiffness values and overall Banff scores, but they used SuperSonic shear imaging. Conversely, other studies have not found SWE to be useful for predicting renal allograft fibrosis, including those by Syversveen et al, 21, 22 Ozkan et al, 20 and Derieppe et al, 31 all of which used ARFI technology. Finally, Gennisson et al 32 studied the effects of US elastography and its associated confounders but in the in vivo pig kidney.
Although this study found no correlation between allograft fibrosis and either the mean or median SWE results within the renal cortex, our study did show a significant correlation between the presence of fibrosis and median SWE results obtained from the medulla. When fibrosis was further divided by severity (mild, moderate, or severe), no SWE results within either compartment showed a significant ability to stage fibrosis severity. Measuring shear wave velocities in the kidney with any modality requires care, as mechanical, anatomic, and functional factors inherent to the organ exist that affect SWE results and interpretation. Clear differences in SWE values were noted between those obtained in the cortex and the medulla. We anticipate that these differences may be attributed to the complicated physiologic and physical factors unique to each compartment of the kidney, including not only anisotropy but also urinary and perfusion pressure effects on each compartment, which was similarly demonstrated by Gennisson et al. 32 We are uncertain why there was correlation between median SWE measurements in the medulla and not the cortex, given the fact fibrosis commonly develops in the cortex. Anatomically, the cortex and medulla are very distinct, so attempting to draw correlations or predict changes between these areas on a histologic level cannot be directly done. A study by Sis et al 33 examined 23 post-transplant biopsy samples that contained both cortical and medullary tissue and found that interstitial inflammation and tubulitis (acute rejection-related lesions) were more severe and more frequently found in the cortex; the renal medulla did not sufficiently reflect cortical rejection; and medullary inflammation was not a valid indicator of allograft rejection. Conversely, our study found the opposite. However, our sample size was small, and our histologic samples contained mainly cortical tissue; therefore, a direct comparison between histologic results of the medulla and SWE results was not exactly performed. Such a comparison could attract attention and be an area of investigation in additional studies, and ultimately, more studies are needed to sufficiently answer this question. Furthermore, the cellular and molecular pathways that regulate both T-cellmediated rejection and antibody-mediated rejection are still not that well understood. 26, 34 Therefore, correlations with the pathologic pathway of acute rejection cannot be entirely made.
Our intraobserver correlations in both the renal cortex and the renal medulla were high. Our interobserver correlations within the renal cortex were also high, indicating good reproducibility between users in cortical SWE measurements. However, interobserver observations within the renal medulla were less correlated, with r 5 0.50 and 0.48 for mean and median medulla SWE results, respectively. This finding raises concerns regarding interobserver reproducibility within the medulla because although the median medulla results were more indicative of fibrosis, they were also more difficult to replicate between multiple users.
Our study highlights the fact that quantification of tissue stiffness in the kidney is substantially more challenging than in other organs, and that US acquisition within a highly anisotropic and tenuous organ is further confounded by mechanical and functional properties. Thus, it is important to realize that accurate values from renal allograft SWE rely not only on clear identification of the orientation of the medullary pyramids but also on other factors, such as vascular and urinary pressure, which were not readily accounted for during this initial pilot study. The allograft location within the lower abdomen/pelvis also affects the elastographic technique, as this superficially placed organ demands a lighter hand while scanning because of a lack of overlying protective structures (such as ribs). Finally, the patient's body habitus (both thin and obese) must be considered. It is well known that increasing depth results in attenuation of the US signal; however, the effects of the depth of the allograft from the transducer (ie, in very obese patients) on SWE have not been clearly established. Preliminary results in our study demonstrate that with our obese patients (obesity being defined as BMI >30 kg/m 2 ), as depth to the allograft increased, there was associated lower SWE results overall. The opposite of this effect is too little depth from the transducer to the underlying organ, such that applied transducer force becomes an issue, as with very thin patients, which was also demonstrated in our study. The effects of applied transducer force were exemplified by Syversveen et al. 22 This factor is demonstrated in Figure 4 , where increased transducer pressure is identified as a compression artifact, shown as areas of dark yellows and red, which correlates with SWE values. Therefore, both applied transducer force (transducer pressure) and the patient's body habitus should be considered when performing the examination. Likewise, both interpretation of SWE results and selection appropriateness for this examination should be considered on an individual basis.
Finally, hydronephrosis and factors adjacent to and within the renal allograft can also alter SWE values. A pre-SWE B-mode US scan is necessary to identify and therefore exclude patients with hydronephrosis, renal artery stenosis, masses, cysts, or other parenchymal disease who may initially be considered for SWE. 17 This idea is supported by data from Gennisson et al, 32 which suggested that patients showing hydronephrosis on initial B-mode US examinations are not candidates for SWE evaluations.
Our study had several limitations. First, our sample size was small. With 70 patients, our data only showed statistical significance in a single category. We anticipate that a larger sample size could have revealed significance in some of our other results, which were trending toward significance. Second, we did not make comparisons between SWE results and additional factors, such as the estimated glomerular filtration rate, serum creatinine level, and time since transplantation, or include Doppler findings (resistive and pulsatility indices) in this initial pilot study. Although these demographic features were recorded and included in our database, further correlations with additional physiologic features were planned for use in subsequent studies. Correlating these factors may have uncovered additional significant findings between renal function and SWE results. Third, we did not have a patient group with severe fibrosis. This factor was likely the result of the possibility that these patients were detected by serologic results and had clinical deterioration compatible with graft failure, therefore precluding the need for biopsy. Finally, we are aware that whereas our median medulla measurements showed statistical significance, most biopsy specimens from our institution contained mainly renal cortical tissue, so a comparison between medulla SWE results and medulla histopathologic biopsy results was not directly performed.
In conclusion, detecting and quantifying fibrosis in renal allografts by using US-based SWE remains substantially more challenging than in the liver, and the utility of this technology remains conflicting. One goal of our study was to describe our elastographic technique in detail, in an attempt to define a reproducible and standardized technique. Although our study did not find significant correlations between either the mean or median SWE values from the renal cortex, our median medulla SWE results do suggest a relationship between SWE and the presence of fibrosis. At this time, we do not think that US-based elastography can replace biopsy, as it is still investigational, and a standard technique for performing examinations should be established. Nonetheless, we do believe that SWE may aid in patient selection for biopsy, thus reducing morbidity for some. Our initial elastographic results are encouraging; however, further investigation with a larger population size is needed to validate our SWE technique, confirm emerging trends in our data, and establish reproducibility.
